Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren

Showing results (211-220 of 1,117) with videos related to

Pageof 112
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2017
New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United StatesKarl Kieburtz, Russell Katz, C Warren Olanow
Optics Express|February 12, 2014
Exposed core microstructured optical fiber Bragg gratings: refractive index sensingStephen C Warren-Smith, Tanya M Monro
The Training School Bulletin|February 1, 1974
Volunteer rehabilitators: a pilot projectJ Hubka, L W Talkington, C Warren
The Journal of Biological Chemistry|August 25, 1973
Affinity labeling of steroid binding sites. Study of the active site of 20-beta-hydroxysteroid dehydrogenase with 6-beta- and 11 alpha-bromoacetoxyprogesteroneF Arias, F Sweet, J C Warren
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Treatment of levodopa-induced motor complicationsFabrizio Stocchi, Michele Tagliati, C Warren Olanow
Annals of Neurology|July 25, 2006
Proteasome inhibitor-induced model of Parkinson's diseaseKevin St P McNaught, C Warren Olanow
Journal of the American Dental Association (1939)|June 1, 1987
Professional fees for special groupsA Doherty, R C Warren, J Sheats
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2014
Initiating levodopa therapy for Parkinson's diseaseC Warren Olanow, Karl Kieburtz, Fabrizio Stocchi
Molecular Biology of the Cell|June 16, 2006
Infection with replication-deficient adenovirus induces changes in the dynamic instability of host cell microtubulesJames C Warren, Adam Rutkowski, Lynne Cassimeris
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2018
Huntington's disease: Current and future therapeutic prospectsKarl Kieburtz, Ralf Reilmann, C Warren Olanow
Pageof 112

Showing results (211-220 of 1,117) with videos related to

Sort By:
Pageof 112
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2017
New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United StatesKarl Kieburtz, Russell Katz, C Warren Olanow
Optics Express|February 12, 2014
Exposed core microstructured optical fiber Bragg gratings: refractive index sensingStephen C Warren-Smith, Tanya M Monro
The Training School Bulletin|February 1, 1974
Volunteer rehabilitators: a pilot projectJ Hubka, L W Talkington, C Warren
The Journal of Biological Chemistry|August 25, 1973
Affinity labeling of steroid binding sites. Study of the active site of 20-beta-hydroxysteroid dehydrogenase with 6-beta- and 11 alpha-bromoacetoxyprogesteroneF Arias, F Sweet, J C Warren
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Treatment of levodopa-induced motor complicationsFabrizio Stocchi, Michele Tagliati, C Warren Olanow
Annals of Neurology|July 25, 2006
Proteasome inhibitor-induced model of Parkinson's diseaseKevin St P McNaught, C Warren Olanow
Journal of the American Dental Association (1939)|June 1, 1987
Professional fees for special groupsA Doherty, R C Warren, J Sheats
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2014
Initiating levodopa therapy for Parkinson's diseaseC Warren Olanow, Karl Kieburtz, Fabrizio Stocchi
Molecular Biology of the Cell|June 16, 2006
Infection with replication-deficient adenovirus induces changes in the dynamic instability of host cell microtubulesJames C Warren, Adam Rutkowski, Lynne Cassimeris
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2018
Huntington's disease: Current and future therapeutic prospectsKarl Kieburtz, Ralf Reilmann, C Warren Olanow
Pageof 112